Cargando…
Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression
LIGHT is a member of the tumor necrosis factor superfamily, which has been claimed to mediate anti-tumor activity on the basis of cancer cures observed in immunocompetent mice bearing transgenic LIGHT-expressing tumors. The preclinical development of a LIGHT-based therapeutic has been hindered by th...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808322/ https://www.ncbi.nlm.nih.gov/pubmed/33404287 http://dx.doi.org/10.1080/19420862.2020.1868066 |